ÂÜÀòÂÒÂ×

Ravi Kurukulasuriya began their career in 1997 at Abbott as a Research Scientist in Process Research and Development. Ravi worked there until 2007 before moving to Pfizer, where they continued as a Research Scientist in Medicinal Chemistry until 2009. From 2009 to 2017, Ravi worked at Merck in the same role. After leaving Merck, they joined Relay Therapeutics as a Research Scientist in Medicinal Chemistry from 2017 to 2021. In 2022, Ravi worked at Roivant Sciences before moving to their current position at Covant Therapeutics as a Research Scientist in Medicinal Chemistry.

Ravi Kurukulasuriya completed their Bachelor of Science degree in Chemistry/Biology from Pacific University between the years 1990 and 1994. Ravi further pursued their education and obtained a Master of Science degree in Organic Chemistry from Purdue University, studying from 1994 to 1997.